Cite
The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM.
MLA
Koga, Tomohiro, et al. “The Diagnostic Utility of Anti-Melanoma Differentiation-Associated Gene 5 Antibody Testing for Predicting the Prognosis of Japanese Patients with DM.” Rheumatology (Oxford, England), vol. 51, no. 7, July 2012, pp. 1278–84. EBSCOhost, https://doi.org/10.1093/rheumatology/ker518.
APA
Koga, T., Fujikawa, K., Horai, Y., Okada, A., Kawashiri, S.-Y., Iwamoto, N., Suzuki, T., Nakashima, Y., Tamai, M., Arima, K., Yamasaki, S., Nakamura, H., Origuchi, T., Hamaguchi, Y., Fujimoto, M., Ishimatsu, Y., Mukae, H., Kuwana, M., Kohno, S., … Kawakami, A. (2012). The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM. Rheumatology (Oxford, England), 51(7), 1278–1284. https://doi.org/10.1093/rheumatology/ker518
Chicago
Koga, Tomohiro, Keita Fujikawa, Yoshiro Horai, Akitomo Okada, Shin-Ya Kawashiri, Naoki Iwamoto, Takahisa Suzuki, et al. 2012. “The Diagnostic Utility of Anti-Melanoma Differentiation-Associated Gene 5 Antibody Testing for Predicting the Prognosis of Japanese Patients with DM.” Rheumatology (Oxford, England) 51 (7): 1278–84. doi:10.1093/rheumatology/ker518.